---
figid: PMC5069291__fnins-10-00459-g0002
figlink: /pmc/articles/PMC5069291/figure/F2/
number: F2
caption: A schematic model of the Wnt/beta-catenin pathway in Alzheimer disease. In
  AD, the “on state” of canonical Wnt/beta-catenin pathway is interrupted at two potential
  levels. Firstly, extracellular Aβ activates DKK1 which inhibits the interaction
  between Wnt and LRP 5/6. Binding of Wnt to Fzd is suppressed and Dsh dissociates
  from Fzd/Axin and migrates to the cytosol. The recruitment of the destruction complex
  to the plasma membrane is suppressed. Inactivation of Dsh leads to stimulation of
  GSK-3β. Thus, APC and AXIN interact with GSK-3β and beta-catenin (Wnt “off state”).
  Beta-catenin is phosphorylated by GSK-3β. The destruction complex AXIN/APC/GSK-3β
  is activated and enhances the destruction process of beta-catenin in the proteasome.
  Secondly, PPAR gamma which is activated by agonists can inhibit the beta-catenin/TCF/LEF
  complex in the nucleus, thus inhibiting the transcription of Wnt target genes. Amyloid
  precursor protein (APP) can be cut into various fragments by α, β, and γ secretases.
  PPAR α activates the transcription of α secretase. Abbreviations APC, adenomatous
  polyposis coli; Dsh, Disheveled; Fzd, Frizzled; GSK-3β, glycogen synthase kinase-3beta;
  LRP5/6, low density lipoprotein receptor-related protein 5/6; TCF/LEF, T-cell factor
  /lymphoid enhancer factor; sAPPα, soluble APPα ectodomain; sAPPβ, soluble APPβ ectodomain;
  APP, Amyloid precursor protein; α, β, and γ, α, β, and γ secretases; Aβ, amyloid
  β peptide; DKK1, Dickkopf-related protein1.
pmcid: PMC5069291
papertitle: 'Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway
  and PPARs Alpha and Gamma.'
reftext: Alexandre Vallée, et al. Front Neurosci. 2016;10:459.
pmc_ranked_result_index: '109937'
pathway_score: 0.9555135
filename: fnins-10-00459-g0002.jpg
figtitle: Schematic model of the Wnt/beta-catenin pathway in Alzheimer disease
year: '2016'
organisms: Homo sapiens
ndex: 991a5c73-dec0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5069291__fnins-10-00459-g0002.html
  '@type': Dataset
  description: A schematic model of the Wnt/beta-catenin pathway in Alzheimer disease.
    In AD, the “on state” of canonical Wnt/beta-catenin pathway is interrupted at
    two potential levels. Firstly, extracellular Aβ activates DKK1 which inhibits
    the interaction between Wnt and LRP 5/6. Binding of Wnt to Fzd is suppressed and
    Dsh dissociates from Fzd/Axin and migrates to the cytosol. The recruitment of
    the destruction complex to the plasma membrane is suppressed. Inactivation of
    Dsh leads to stimulation of GSK-3β. Thus, APC and AXIN interact with GSK-3β and
    beta-catenin (Wnt “off state”). Beta-catenin is phosphorylated by GSK-3β. The
    destruction complex AXIN/APC/GSK-3β is activated and enhances the destruction
    process of beta-catenin in the proteasome. Secondly, PPAR gamma which is activated
    by agonists can inhibit the beta-catenin/TCF/LEF complex in the nucleus, thus
    inhibiting the transcription of Wnt target genes. Amyloid precursor protein (APP)
    can be cut into various fragments by α, β, and γ secretases. PPAR α activates
    the transcription of α secretase. Abbreviations APC, adenomatous polyposis coli;
    Dsh, Disheveled; Fzd, Frizzled; GSK-3β, glycogen synthase kinase-3beta; LRP5/6,
    low density lipoprotein receptor-related protein 5/6; TCF/LEF, T-cell factor /lymphoid
    enhancer factor; sAPPα, soluble APPα ectodomain; sAPPβ, soluble APPβ ectodomain;
    APP, Amyloid precursor protein; α, β, and γ, α, β, and γ secretases; Aβ, amyloid
    β peptide; DKK1, Dickkopf-related protein1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPARA
  - FZD9
  - GSK3B
  - LRP5
  - FZD8
  - WNT2B
  - APC
  - APP
  - LRP6
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - FZD10
  - WNT9B
  - WNT10A
  - WNT5B
  - WNT3A
  - AXIN1
  - AXIN2
  - CTNNB1
  - DKK1
  - WNT1
  - FZD1
  - WNT16
  - WNT4
  - FZD7
  - WNT11
  - FZD4
  - FZD6
  - WNT10B
  - WNT5A
  - WNT9A
  - WNT2
  - WNT3
  - FZD2
  - FZD5
  - FZD3
genes:
- word: PPARA
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: APP
  symbol: APP
  source: hgnc_symbol
  hgnc_symbol: APP
  entrez: '351'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: DKK-1
  symbol: DKK-1
  source: hgnc_alias_symbol
  hgnc_symbol: DKK1
  entrez: '22943'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
chemicals: []
diseases: []
figid_alias: PMC5069291__F2
redirect_from: /figures/PMC5069291__F2
figtype: Figure
---
